Thomas J. Herzfeld Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-1,700
Closed -$98.7K – 183
2023
Q3
$98.7K Hold
1,700
– – 0.04% 107
2023
Q2
$109K Hold
1,700
– – 0.04% 94
2023
Q1
$118K Hold
1,700
– – 0.05% 82
2022
Q4
$122K Hold
1,700
– – 0.05% 87
2022
Q3
$121K Hold
1,700
– – 0.05% 83
2022
Q2
$131K Hold
1,700
– – 0.05% 92
2022
Q1
$124K Hold
1,700
– – 0.05% 100
2021
Q4
$106K Hold
1,700
– – 0.04% 120
2021
Q3
$101K Hold
1,700
– – 0.04% 104
2021
Q2
$114K Hold
1,700
– – 0.05% 109
2021
Q1
$107K Hold
1,700
– – 0.05% 118
2020
Q4
$105K Hold
1,700
– – 0.05% 119
2020
Q3
$99K Hold
1,700
– – 0.07% 77
2020
Q2
$100K Hold
1,700
– – 0.05% 112
2020
Q1
$95K Hold
1,700
– – 0.05% 108
2019
Q4
$109K Hold
1,700
– – 0.04% 111
2019
Q3
$86K Hold
1,700
– – 0.03% 132
2019
Q2
$77K Hold
1,700
– – 0.03% 146
2019
Q1
$81K Hold
1,700
– – 0.03% 159
2018
Q4
$88K Hold
1,700
– – 0.04% 153
2018
Q3
$106K Hold
1,700
– – 0.04% 136
2018
Q2
$94K Hold
1,700
– – 0.03% 155
2018
Q1
$108K Hold
1,700
– – 0.04% 148
2017
Q4
$104K Hold
1,700
– – 0.04% 153
2017
Q3
$108K Hold
1,700
– – 0.05% 141
2017
Q2
$95K Hold
1,700
– – 0.04% 148
2017
Q1
$92K Hold
1,700
– – 0.04% 167
2016
Q4
$99K Hold
1,700
– – 0.05% 159
2016
Q3
$92K Buy
+1,700
New +$109K 0.05% 148

Other funds holding BMY

Thomas J. Herzfeld Advisors's BMY Position: Q4 2023 in Review

Thomas J. Herzfeld Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 1,700 shares — an estimated $98.7K sold.

Thomas J. Herzfeld Advisors first reported a position in BMY in Q3 2016 and held it in 29 quarters. The position peaked at $131K in Q2 2022. 2,366 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Thomas J. Herzfeld Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • Thomas J. Herzfeld Advisors sold 1,700 Bristol-Myers Squibb shares in Q4 2023, an estimated $98.7K.
  • Thomas J. Herzfeld Advisors first reported a position in Bristol-Myers Squibb in Q3 2016 and held it in 29 quarters.
  • Thomas J. Herzfeld Advisors's Bristol-Myers Squibb position peaked at $131K in Q2 2022.
  • 2,366 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.